SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001833141-24-000001
Filing Date
2024-02-14
Accepted
2024-02-14 08:17:14
Documents
9
Period of Report
2024-02-14

Document Format Files

Seq Description Document Type Size
1 6-K cybininc-form6xkq3x2024.htm 6-K 14419
2 EX-99.1 cybinincfs-q3x24xfinalxdec.htm EX-99.1 614418
3 EX-99.2 cybin-mdaxq3x24xfinalxdece.htm EX-99.2 1128091
4 EX-99.3 q32023-ceocertificate_cybin.htm EX-99.3 12669
5 EX-99.4 q32023-cfocertificate_cybin.htm EX-99.4 12710
6 EX-99.5 cybnq32024-earningsprfinal.htm EX-99.5 41124
7 GRAPHIC image_0.jpg GRAPHIC 10741
8 GRAPHIC image_0a.jpg GRAPHIC 10741
9 GRAPHIC image_0b.jpg GRAPHIC 14343
  Complete submission text file 0001833141-24-000001.txt   1874246
Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Filer) CIK: 0001833141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40673 | Film No.: 24632515
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)